Literature DB >> 6835406

A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells.

D R Senger, B B Asch, B D Smith, C A Perruzzi, H F Dvorak.   

Abstract

A wide variety of virally and spontaneously transformed fibroblasts secrete a major transformation-related phosphoprotein with a molecular weight (MW), depending on the species of origin, of about 62,000 (62K). Markedly elevated extracellular levels of this major 32P-labelled protein are not simply linked to exponential growth but instead are associated directly with transformation. The phosphoprotein is not antigenically related to p60src, p60c-src or simian virus 40 (SV40) non-viral T antigen, and it is further distinguishable from SV40 non-viral T antigen (pp 53) on the basis of its electrophoretic mobility. In this study we have compared a variety of normal and transformed epithelial cells for secretion of this 32P-labelled protein and have found that this marker distinguishes neoplastic from preneoplastic and normal mouse mammary epithelium and also identifies highly tumorigenic cells derived from guinea pig bile duct epithelium and rat liver epithelium. Because the classical phenotypic properties commonly associated with transformation of fibroblasts cannot be generally used to discriminate tumorigenic from non-tumorigenic epithelial cells, this phosphoprotein, which identifies tumorigenic cells of both fibroblastic and epithelial origin, is likely to be of particular importance.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6835406     DOI: 10.1038/302714a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  20 in total

Review 1.  Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules.

Authors:  G E Davis; K J Bayless; M J Davis; G A Meininger
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

2.  Calcitriol enhancement of TPA-induced tumorigenic transformation is mediated through vitamin D receptor-dependent and -independent pathways.

Authors:  P L Chang; T F Lee; K Garretson; C W Prince
Journal:  Clin Exp Metastasis       Date:  1997-11       Impact factor: 5.150

3.  Altered processing of a major secreted phosphoprotein correlates with tumorigenicity in Rous sarcoma virus-transformed mammalian cells.

Authors:  I Chackalaparampil; D Banerjee; Y Poirier; B B Mukherjee
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

Review 4.  Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation.

Authors:  A O'Regan; J S Berman
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

5.  Occurrence of potential cruciform and H-DNA forming sequences in genomic DNA.

Authors:  G P Schroth; P S Ho
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

6.  Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice.

Authors:  Takashi Nomiyama; Diego Perez-Tilve; Daisuke Ogawa; Florence Gizard; Yue Zhao; Elizabeth B Heywood; Karrie L Jones; Ryuzo Kawamori; Lisa A Cassis; Matthias H Tschöp; Dennis Bruemmer
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

7.  Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells.

Authors:  Priyanka Sharma; Santosh Kumar; Gopal C Kundu
Journal:  Mol Cancer       Date:  2010-07-07       Impact factor: 27.401

Review 8.  Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer.

Authors:  Akeila Bellahcène; Vincent Castronovo; Kalu U E Ogbureke; Larry W Fisher; Neal S Fedarko
Journal:  Nat Rev Cancer       Date:  2008-03       Impact factor: 60.716

9.  Osteopontin expression and distribution in human carcinomas.

Authors:  L F Brown; A Papadopoulos-Sergiou; B Berse; E J Manseau; K Tognazzi; C A Perruzzi; H F Dvorak; D R Senger
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

10.  Osteopontin regulates ubiquitin-dependent degradation of Stat1 in murine mammary epithelial tumor cells.

Authors:  Chengjiang Gao; Zhiyong Mi; Hongtao Guo; Paul C Kuo
Journal:  Neoplasia       Date:  2007-09       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.